申请人:——
公开号:US20020028831A1
公开(公告)日:2002-03-07
(4-oxy-3-(aryl)phenyl)pyridine compounds, in free or acid addition salt form, are useful as pharmaceuticals for treatment and prophylaxis of inflammation, particularly inflammatory or obstructive diseases of the airways, e.g. for asthma therapy. Preferred compounds are novel biphenyl pyridines, biphenyl benzamides and biphenyl phenylcarboxy compounds. The compounds are selective inhibitors of PDE 4 isoenzyme activity and also act to down regulate or inhibit TNF-&agr; release.
(4-氧代-3-(芳基)苯基)吡啶化合物,以自由形式或酸盐形式,作为药物用于治疗和预防炎症,特别是空气道的炎症或阻塞性疾病,例如哮喘治疗。优选的化合物是新型的联苯基吡啶、联苯基苯甲酰胺和联苯基苯基羧酸化合物。这些化合物是PDE 4同工酶活性的选择性抑制剂,同时也可以下调或抑制TNF-α的释放。